Trends in FDA drug approvals: 2021–2024 insights & innovations
Annales Pharmaceutiques Françaises · 2025-11 · 83 (6) · 1062-1072
DOI: 10.1016/j.pharma.2025.06.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annales Pharmaceutiques Françaises, 2025-11. Verfasst von Geet Raut und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's, NMIMS, Deemed to be University, Vile Parle West, 400056 Mumbai, Mahara…. Hauptthemen laut MEDLINE: Drug Approval. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 102 Literaturangaben.
Abstract (Originalsprache)
From 2021-2024, the U.S. Food and Drug Administration (FDA) approved novel drugs, advancing treatments in neurology, oncology, infectious diseases and rare disorders. This review analyzes approval trends, highlighting the targeted diseases and biologics, the rise of expedited pathways and focus on unmet medical needs. These examines key therapeutic areas the approval trends of different categories. The analysis draws on data from the FDA's Center for Drug Evaluation and Research (CDER) to provide insights into novel drug indication, regulatory innovations and their implications to healthcare. The review analyzes trends in drug approvals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's, NMIMS, Deemed to be University, Vile Parle West, 400056 Mumbai, Maharashtra, India.
- Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's, NMIMS, Deemed to be University, Vile Parle West, 400056 Mumbai, Maharashtra, India. Electronic address: sanjaysharma.qa@gmail.com.
Zitieren
APA
Raut, G., & Sharma, S. (2025). Trends in FDA drug approvals: 2021–2024 insights & innovations. Annales Pharmaceutiques Françaises, 83(6), 1062-1072. https://doi.org/10.1016/j.pharma.2025.06.004
Vancouver
Raut G, Sharma S. Trends in FDA drug approvals: 2021–2024 insights & innovations. Annales Pharmaceutiques Françaises. 2025;83(6):1062-1072. doi:10.1016/j.pharma.2025.06.004
BibTeX
@article{Raut2025,
author = {Raut, Geet and Sharma, Sanjay},
title = {Trends in FDA drug approvals: 2021–2024 insights & innovations},
journal = {Annales Pharmaceutiques Françaises},
year = {2025},
volume = {83},
number = {6},
pages = {1062--1072},
doi = {10.1016/j.pharma.2025.06.004}
}
EUVIMED